PERIPHERAL T-CELL LYMPHOMA, NOT OTHERWISE SPECIFIED

Clinical trials for PERIPHERAL T-CELL LYMPHOMA, NOT OTHERWISE SPECIFIED explained in plain language.

Never miss a new study

Get alerted when new PERIPHERAL T-CELL LYMPHOMA, NOT OTHERWISE SPECIFIED trials appear

Sign up with your email to follow new studies for PERIPHERAL T-CELL LYMPHOMA, NOT OTHERWISE SPECIFIED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 2 Not yet finished but already full! 3 Terminated 1

Personalized immune cells target Tough-to-Treat lymphoma

Disease control Terminated

This study tested a personalized cell therapy called AUTO4 for adults with specific types of T-cell lymphoma that had returned or stopped responding to standard treatments. Doctors collected a patient's own immune cells, engineered them in a lab to better target the cancer, and t…

Matched conditions: PERIPHERAL T-CELL LYMPHOMA, NOT OTHERWISE SPECIFIED

Phase: PHASE1, PHASE2 • Sponsor: Autolus Limited • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

PERIPHERAL T-CELL LYMPHOMA, NOT OTHERWISE SPECIFIED

Get alerted when new PERIPHERAL T-CELL LYMPHOMA, NOT OTHERWISE SPECIFIED trials appear

Personalized immune cells target Tough-to-Treat lymphoma